Stéphane Bancel, Moderna CEO (Getty Images)
August 28, 2020 07:09 AM EDTUpdated 09:31 AM
Coronavirus

Covid-19 roundup: J&J launch­ing new PhII vac­cine tri­als in Eu­rope; Ab­bott scores $760M test­ing kit or­der from HHS

Max Gelman

Senior Editor

Nicole DeFeudis

Editor

Amber Tong

As J&J plans to roll out Phase III test­ing for its Covid-19 vac­cine some­time next month, the big phar­ma is plan­ning ad­di­tion­al Phase II tri­als …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

No­var­tis pays $150M up­front to Schrödinger in new drug deal, ramps up soft­ware use

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times